# Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy

> **NCT00910325** · PHASE1,PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Cholelithiasis

## Interventions

- **PROCEDURE:** Laparoscopic-assisted transvaginal cholecystectomy

## Key facts

- **NCT ID:** NCT00910325
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The alternative laparoscopic chole, has so little morbidity very few patients opt for a transvaginal approach when presented with the alternative
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910325, "Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00910325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*